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 Mesenchymal stem cells (MSCs) have differentiation capacity to multi lineage cells, 
such as osteoblasts. As has been reported recently, osteogenic differentiation can be 
regulated by microRNAs. Although platelet-rich plasma (PRP) is used in the 
osteogenic differentiation process, the molecular mechanism of the effect of PRP on 
the induction of osteogenic differentiation by microRNAs is not well understood. 
We evaluated the effect of PRP on the expression of mir-29a as a key microRNA on 
the osteogenic differentiation process of hMSCs. 
Methods and Results: 
Mesenchymal cells were isolated from human adipose tissue and differentiated into 
osteoblasts. The effects of 10% PRP on bone differentiation evaluate by alkaline 
phosphatase activity and calcium deposition. We also evaluated gene expression of 
Runx2 and OPN along with the expression of mir-29a by Real-time PCR. Adipose-
derived cells with differentiation potential to adipocyte and osteoblast cell lines, 
show significant increase in osteoblast differentiation rate, enzyme activity, 
mineralization upregulation of the mir-29a and gene markers when treated by 10% 
PRP. 
Conclusion: 
The present study showed that micro-RNAs such as mir-29a seem to play an active 
role in the process of bone differentiation during PRP treatment, which in turn 
affects the signaling pathways of mesenchymal stem cells. Determining the signaling 
pathways of PRP effect on osteogenic differentiation can optimize the use of this 
substance in the cell therapy for bone injury and fracture. 
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